Amgen has terminated its collaboration with Kyowa Kirin on the atopic dermatitis drug rocatinlimab, handing full development rights back to the Japanese partner. The strategic shift comes as Amgen's stock trades above most fair value estimates, raising questions about its current valuation amid pipeline recalibration.
Shares of cybersecurity firm Gen Digital have tumbled over 7% in a week, pushing its valuation metrics below industry averages. A deep dive into its cash flows and earnings multiples suggests the market may be undervaluing the consumer digital safety provider.
Compass Point Research suggests the prolonged cryptocurrency downturn may be nearing its end, with Bitcoin finding a potential bottom around $60,000-$68,000 unless broader market turmoil intervenes.
The pharmaceutical giant is set to release quarterly results before the bell Wednesday, with Wall Street anticipating another period of blockbuster revenue growth driven by its GLP-1 drugs.
Markel Group is set to report its latest quarterly earnings after the bell Wednesday. Investors will be watching to see if the insurer can build on last quarter's strong performance amid a challenging market for property and casualty stocks.
As the RBA's policy decisions loom, investors are scouring the market for resilient opportunities. We spotlight three ASX-listed penny stocks—Aura Energy, Beam Communications, and Count Limited—each with a market cap over A$10 million, offering a blend of high-risk potential and strategic positioning in their respective sectors.
As ePlus prepares to release its fourth-quarter results, investors are weighing strong past performance against a history of revenue misses and a cautious growth outlook for the current period.
Despite a significant stock pullback following its transformative $4.1 billion acquisition of Paycor, Paychex (PAYX) presents a compelling case for patient investors. This analysis explores the strategic rationale behind the deal, near-term integration pressures, and the long-term defensive appeal of its recurring-revenue model in a volatile market for small-business services.
Brazil's state-controlled oil giant Petrobras is trading at deep value multiples, offering investors a covered dividend yield near 10%. Analysts argue its disciplined payout and exposure to a tightening global oil market create a rare mix of income and asymmetric upside.
Cronos Group's stock has rallied on renewed optimism for U.S. cannabis reform. We examine the regulatory shift, strategic positioning, and long-term potential driving investor sentiment.
Amid market volatility, a detailed analysis circulating among value investors makes a case for Kimberly-Clark Corporation. The thesis highlights the household products maker's resilient business model, technical support levels, and a valuation disconnect that could signal a compelling entry point for long-term portfolios.
The NAND flash memory specialist's stock skyrocketed last month, propelled by surging prices and blockbuster earnings that smashed Wall Street estimates, highlighting its pivotal role in the AI infrastructure build-out.
Amidst market volatility, EVERTEC Inc. (EVTC) presents a compelling investment case. Trading at depressed valuation multiples, the Latin American transaction processing leader combines a 'boring but consistent' operational profile with significant potential for multiple expansion and steady growth, offering a unique risk/reward balance for patient investors.
As Archer Aviation advances toward FAA certification for its Midnight air taxi, bullish investors point to its strong liquidity and strategic partnerships. But with the company still pre-revenue and burning cash, the path to commercial launch by 2026 remains a high-stakes race against time and regulation.
While positioned at the forefront of the small modular reactor (SMR) revolution, NuScale Power remains a pre-revenue manufacturer with significant hurdles to clear before it can deliver on its potential as a growth—and eventual dividend—story for investors.
SanDisk (NASDAQ: SNDK) and Kioxia have renewed their flash memory joint venture for another five years, a strategic move aimed at securing advanced 3D NAND production capacity and supply chains through 2034 to meet the explosive storage needs of artificial intelligence.
Hecla Mining's stock soared nearly 300% in 2025, fueled by surging silver and gold prices. While the company's financials have transformed, its dividend policy remains a point of contention for income-focused investors.
Amid a cautious retail environment, Ollie's Bargain Outlet (OLLI) is posting impressive growth by leaning into aggressive pricing and rapid store expansion. Its latest earnings beat and a fortified loyalty program are painting a compelling picture for long-term investors, even as valuation questions linger.
ResMed Inc., the sleep therapy giant, faces a pivotal moment. While benefiting from a competitor's recall and a growing market funnel, emerging oral treatments and shifting dynamics pose fresh challenges to its long-held CPAP business model.
With voter registration closing Monday night, Texas gears up for a pivotal March primary. East Texas Democrats express cautious optimism about statewide prospects, while Republicans remain confident in their stronghold as key races take shape.
